Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Purchase of Shares by Director
Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces that Andy Williams, Non-Executive Director, has today purchased 179,484 ordinary shares in the Company at 51.5 pence and following this Mr Williams holds 889,968 ordinary shares, representing 0.97 per cent. of the Company's current issued share capital.
In the announcement released at 7.00 a.m. today, Mr Williams' shareholding was incorrectly shown as 610,484 shares when it should have been 710,484 shares. Similarly, Dr Hugo Stephenson's shareholding was shown as 2,226,273 shares when it should have been 2,256,273 shares.
ENQUIRIES
| Induction James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer | Via Walbrook PR Ltd: induction@walbrookpr.com |
| | |
| Singer Capital Markets (Nominated Adviser and Broker) | +44 (0)20 7496 3000 |
| Philip Davies / Kailey Aliyar | |
| | |
| Walbrook PR Ltd | |
| Paul McManus / Alice Woodings | Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 |
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - enabling a more flexible, efficient and positive experience for the communities they serve. Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a. | Name | Andy Williams |
| 2. | Reason for the notification | |
| a. | Position/status | Non-Executive Director |
| a. | Initial notification /Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a. | Name | Induction Healthcare Group plc |
| b. | LEI | 213800RY96GCZQW5TP19 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 0.5 pence each
GB00BJ0M3545 |
| b. | Nature of the transaction | Purchase of Ordinary Shares |
| c. | Price(s) and volume(s) | 51.5 pence 179,484 Ordinary Shares |
| d. | Aggregated information ·Aggregated volume ·Price | N/A |
| e. | Date of the transaction | 12 April 2022 |
| f. | Place of the transaction | London Stock Exchange |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.